Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Grip Strength
Public ClinicalTrials.gov record NCT06613022. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy adult volunteers. The main questions it aims to answer are: * Does IASTM treatment have an effect on range of motion (ROM) as measured in the elbow, wrist and thumb? * Does IASTM treatment have an effect on grip strength? Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change ROM and/or grip strength. Participants will: * Complete a questionnaire on medical history and injury background * Have elbow, wrist, and thumb range of motion (ROM) measurements taken on both upper extremities using a goniometer * Undergo grip strength testing using a JAMAR hand dynamometer in three positions on both upper extremities * Be randomly assigned to either IASTM first treatment group or the wait/control first group * Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the forearm wrist flexors and wrist extensors and the biceps and triceps using the HG8-Scanner tool and then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) in each direction for a total treatment time of 20 minutes for both upper extremities in all listed areas. * Simply wait for 20 minutes (the duration of time treatment with IASTM would require) when assigned to the control group. * Complete elbow, wrist and thumb range of motion and grip strength measurement testing at the end of the first session. * Return within fourteen days after the first session in order to undergo the opposite experience (IASTM first means wait/control second and vice versa). * Undergo the same baseline pre-test measurements for range of motion and grip strength as the first session. * Experience the opposite treatment group for the same time period as the first session. * Undergo the post-test range of motion and grip strength testing at the end of the second session for data comparison.
Study identification
- NCT ID
- NCT06613022
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Interventions
- Instrument Assisted Soft Tissue Mobilization first Control second Other
- Control first Instrument Assisted Soft Tissue Mobilization second Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 7, 2024
- Primary completion
- Feb 28, 2024
- Completion
- Feb 28, 2024
- Last update posted
- Sep 24, 2024
2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Minot State University | Minot | North Dakota | 58707 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06613022, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2024 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06613022 live on ClinicalTrials.gov.